Clinical Trial Update: A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetics study evaluated ceftobiprole in obese patients. The trial status indicates completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Staphylococcal Skin Infection
• Streptococcal Infections

Drugs mentioned

• ceftobiprole (ceftobiprole)

Snippet

Sponsor: Basilea Pharmaceutica | Conditions: Obesity, Staphylococcal Skin Infections | Phase 1 | Status: COMPLETED